CoChat

Neuroinflammation and Post-Stroke Depression: Focus on the Microglia and Astrocytes

Lu, Weizhuo, Wen, Jiyue · 2025 · Aging and disease
Cited by 54

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14336/ad.2024.0214-1

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Research works printed but not linked: 135

  1. Gaete JM, Bogousslavsky J (2008). Post-stroke depression. Expert Rev Neurother, 8:75-92. · DOI · Paper page
  2. Staub F, Bogousslavsky J (2001). Post-stroke depression or fatigue. Eur Neurol, 45:3-5. · DOI
  3. Paolucci S, Iosa M, Coiro P, Venturiero V, Savo A, De Angelis D, et al. (2019). Post-stroke Depression Increases Disability More Than 15% in Ischemic Stroke Survivors: A Case-Control Study. Front Neurol, 10:926. · DOI
  4. Sibolt G, Curtze S, Melkas S, Pohjasvaara T, Kaste M, Karhunen PJ, et al. (2013). Post-stroke depression and depression-executive dysfunction syndrome are associated with recurrence of ischaemic stroke. Cerebrovasc Dis, 36:336-343. · DOI
  5. Loubinoux I, Kronenberg G, Endres M, Schumann-Bard P, Freret T, Filipkowski RK, et al. (2012). Post-stroke depression: mechanisms, translation and therapy. J Cell Mol Med, 16:1961-1969. · DOI · Paper page
  6. Fan Q, Liu Y, Sheng L, Lv S, Yang L, Zhang Z, et al. (2023). Chaihu-Shugan-San inhibits neuroinflammation in the treatment of post-stroke depression through the JAK/STAT3-GSK3beta/PTEN/Akt pathway. Biomed Pharmacother, 160:114385. · DOI
  7. Kliper E, Bashat DB, Bornstein NM, Shenhar-Tsarfaty S, Hallevi H, Auriel E, et al. (2013). Cognitive decline after stroke: relation to inflammatory biomarkers and hippocampal volume. Stroke, 44:1433-1435. · DOI
  8. Emsley HC, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, et al. (2003). An early and sustained peripheral inflammatory response in acute ischaemic stroke: relationships with infection and atherosclerosis. J Neuroimmunol, 139:93-101. · DOI · Paper page
  9. Chen H, Liu F, Sun D, Zhang J, Luo S, Liao Q, et al. (2022). The potential risk factors of early-onset post-stroke depression from immuno-inflammatory perspective. Front Immunol, 13:1000631. · DOI
  10. Hadidi N, Treat-Jacobson DJ, Lindquist R (2009). Poststroke depression and functional outcome: a critical review of literature. Heart Lung, 38:151-162. · DOI · Paper page
  11. Gaupp R, Berrios GE, Pomarol-Clotet E (2000). Depressive states in old age. (Classic Text No. 42). Hist Psychiatry, 11:213-225. · DOI
  12. Roth M (1955). The natural history of mental disorder in old age. J Ment Sci, 101:281-301. · DOI · Paper page
  13. Folstein MF, Maiberger R, McHugh PR (1977). Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry, 40:1018-1020. · DOI · Paper page
  14. Chen H, Huang X, Zeng C, Sun D, Liu F, Zhang J, et al. (2023). The role of indoleamine 2,3-dioxygenase 1 in early-onset post-stroke depression. Front Immunol, 14:1125634. · DOI
  15. Robinson RG, Kubos KL, Starr LB, Rao K, Price TR (1984). Mood disorders in stroke patients. Importance of location of lesion. Brain, 107(Pt 1):81-93. · DOI · Paper page
  16. Spitzer RL, Kroenke K, Williams JB (1999). Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA, 282:1737-1744. · DOI · Paper page
  17. Medeiros GC, Roy D, Kontos N, Beach SR (2020). Post-stroke depression: A 2020 updated review. Gen Hosp Psychiatry, 66:70-80. · DOI · Paper page
  18. Sinyor D, Amato P, Kaloupek DG, Becker R, Goldenberg M, Coopersmith H (1986). Post-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcome. Stroke, 17:1102-1107. · DOI · Paper page
  19. Baccaro A, Wang YP, Brunoni AR, Candido M, Conforto AB, da Costa Leite C, et al. (2019). Does stroke laterality predict major depression and cognitive impairment after stroke? Two-year prospective evaluation in the EMMA study. Prog Neuropsychopharmacol Biol Psychiatry, 94:109639. · DOI
  20. Bekhbat M, Neigh GN (2018). Sex differences in the neuro-immune consequences of stress: Focus on depression and anxiety. Brain Behav Immun, 67:1-12. · DOI · Paper page
  21. Starkstein SE, Robinson RG, Price TR (1987). Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain, 110(Pt 4):1045-1059. · DOI · Paper page
  22. Kim JS, Choi-Kwon S (2000). Poststroke depression and emotional incontinence: correlation with lesion location. Neurology, 54:1805-1810. · DOI · Paper page
  23. Morris PL, Robinson RG, Raphael B, Hopwood MJ (1996). Lesion location and poststroke depression. J Neuropsychiatry Clin Neurosci, 8:399-403. · DOI · Paper page
  24. Klingbeil J, Brandt ML, Wawrzyniak M, Stockert A, Schneider HR, Baum P, et al. (2021). Association of Lesion Location and Depressive Symptoms Poststroke. Stroke, 52:830-837. · DOI
  25. Hama S, Yamashita H, Shigenobu M, Watanabe A, Kurisu K, Yamawaki S, et al. (2007). Post-stroke affective or apathetic depression and lesion location: left frontal lobe and bilateral basal ganglia. Eur Arch Psychiatry Clin Neurosci, 257:149-152. · DOI
  26. Terroni L, Amaro E, Iosifescu DV, Tinone G, Sato JR, Leite CC, et al. (2011). Stroke lesion in cortical neural circuits and post-stroke incidence of major depressive episode: a 4-month prospective study. World J Biol Psychiatry, 12:539-548. · DOI
  27. Liang W, Fan Z, Cui S, Shen X, Wang L (2021). The association between White matter microstructure alterations detected by Diffusional kurtosis imaging in Neural circuit and post-stroke depression. Neurol Res, 43:535-542. · DOI
  28. Lu Y, Liang H, Han D, Mo Y, Li Z, Cheng Y, et al. (2016). The volumetric and shape changes of the putamen and thalamus in first episode, untreated major depressive disorder. Neuroimage Clin, 11:658-666. · DOI · Paper page
  29. Dihne M, Grommes C, Lutzenburg M, Witte OW, Block F (2002). Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats. Stroke, 33:3006-3011. · DOI · Paper page
  30. Santos M, Kovari E, Gold G, Bozikas VP, Hof PR, Bouras C, et al. (2009). The neuroanatomical model of post-stroke depression: towards a change of focus? J Neurol Sci, 283:158-162. · DOI
  31. Narushima K, Kosier JT, Robinson RG (2003). A reappraisal of poststroke depression, intra- and inter-hemispheric lesion location using meta-analysis. J Neuropsychiatry Clin Neurosci, 15:422-430. · doi:10.1176/jnp.15.4.422 · Paper page
  32. Guo J, Wang J, Sun W, Liu X (2022). The advances of post-stroke depression: 2021 update. J Neurol, 269:1236-1249. · DOI · Paper page
  33. Karaahmet OZ, Gurcay E, Avluk OC, Umay EK, Gundogdu I, Ecerkale O, et al. (2017). Poststroke depression: risk factors and potential effects on functional recovery. Int J Rehabil Res, 40:71-75. · DOI
  34. Leonard B, Maes M (2012). Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev, 36:764-785. · DOI · Paper page
  35. Oglodek E (2022). Changes in the Serum Levels of Cytokines: IL-1beta, IL-4, IL-8 and IL-10 in Depression with and without Posttraumatic Stress Disorder. Brain Sci, 12. · DOI
  36. Wang L, Wang R, Liu L, Qiao D, Baldwin DS, Hou R (2019). Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis. Brain Behav Immun, 79:24-38. · DOI · Paper page
  37. Spalletta G, Bossu P, Ciaramella A, Bria P, Caltagirone C, Robinson RG (2006). The etiology of poststroke depression: a review of the literature and a new hypothesis involving inflammatory cytokines. Mol Psychiatry, 11:984-991. · DOI · Paper page
  38. Li R, Fan W, Li D, Liu X (2022). Correlation of common inflammatory cytokines with cognition impairment, anxiety, and depression in acute ischemic stroke patients. Braz J Med Biol Res, 55:e11517. · DOI
  39. Chamorro A, Dirnagl U, Urra X, Planas AM (2016). Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation. Lancet Neurol, 15:869-881. · DOI · Paper page
  40. Shichita T, Ito M, Yoshimura A (2014). Post-ischemic inflammation regulates neural damage and protection. Front Cell Neurosci, 8:319. · DOI · Paper page
  41. Spalletta G, Cravello L, Imperiale F, Salani F, Bossu P, Picchetto L, et al. (2013). Neuropsychiatric symptoms and interleukin-6 serum levels in acute stroke. J Neuropsychiatry Clin Neurosci, 25:255-263. · DOI · Paper page
  42. Hannestad J, DellaGioia N, Bloch M (2011). The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology, 36:2452-2459. · DOI · Paper page
  43. Kim JM, Stewart R, Kim SW, Shin IS, Kim JT, Park MS, et al. (2012). Associations of cytokine gene polymorphisms with post-stroke depression. World J Biol Psychiatry, 13:579-587. · DOI · Paper page
  44. Yang L, Zhang Z, Sun D, Xu Z, Zhang X, Li L (2010). The serum interleukin-18 is a potential marker for development of post-stroke depression. Neurol Res, 32:340-346. · DOI · Paper page
  45. Bossu P, Salani F, Cacciari C, Picchetto L, Cao M, Bizzoni F, et al. (2009). Disease outcome, alexithymia and depression are differently associated with serum IL-18 levels in acute stroke. Curr Neurovasc Res, 6:163-170. · DOI · Paper page
  46. Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M (1999). Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity, 10:127-136. · DOI · Paper page
  47. Kuwahara-Otani S, Maeda S, Kobayashi K, Minato Y, Tanaka K, Yamanishi K, et al. (2017). Interleukin-18 and its receptor are expressed in gonadotropin-releasing hormone neurons of mouse and rat forebrain. Neurosci Lett, 650:33-37. · DOI
  48. Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H (2002). Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci, 22:5910-5919. · DOI · Paper page
  49. Jander S, Schroeter M, Stoll G (2002). Interleukin-18 expression after focal ischemia of the rat brain: association with the late-stage inflammatory response. J Cereb Blood Flow Metab, 22:62-70. · DOI
  50. Russell JM (2000). Sodium-potassium-chloride cotransport. Physiol Rev, 80:211-276. · DOI · Paper page
  51. Goubert E, Altvater M, Rovira MN, Khalilov I, Mazzarino M, Sebastiani A, et al. (2019). Bumetanide Prevents Brain Trauma-Induced Depressive-Like Behavior. Front Mol Neurosci, 12:12. · DOI
  52. Tsukahara T, Masuhara M, Iwai H, Sonomura T, Sato T (2015). Repeated stress-induced expression pattern alterations of the hippocampal chloride transporters KCC2 and NKCC1 associated with behavioral abnormalities in female mice. Biochem Biophys Res Commun, 465:145-151. · DOI
  53. Li Z, Xu H, Xu Y, Lu G, Peng Q, Chen J, et al. (2021). Morinda officinalis oligosaccharides alleviate depressive-like behaviors in post-stroke rats via suppressing NLRP3 inflammasome to inhibit hippocampal inflammation. CNS Neurosci Ther, 27:1570-1586. · DOI
  54. Su JA, Chou SY, Tsai CS, Hung TH (2012). Cytokine changes in the pathophysiology of poststroke depression. Gen Hosp Psychiatry, 34:35-39. · DOI
  55. Korostynski M, Hoinkis D, Piechota M, Golda S, Pera J, Slowik A, et al. (2021). Toll-like receptor 4-mediated cytokine synthesis and post-stroke depressive symptoms. Transl Psychiatry, 11:246. · DOI
  56. Ting EY, Yang AC, Tsai SJ (2020). Role of Interleukin-6 in Depressive Disorder. Int J Mol Sci, 21. · DOI · Paper page
  57. Girotti M, Donegan JJ, Morilak DA (2013). Influence of hypothalamic IL-6/gp130 receptor signaling on the HPA axis response to chronic stress. Psychoneuroendocrinology, 38:1158-1169. · DOI · Paper page
  58. Anderson G, Kubera M, Duda W, Lason W, Berk M, Maes M (2013). Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression. Pharmacol Rep, 65:1647-1654. · DOI · Paper page
  59. Euteneuer F, Dannehl K, Del Rey A, Engler H, Schedlowski M, Rief W (2017). Peripheral Immune Alterations in Major Depression: The Role of Subtypes and Pathogenetic Characteristics. Front Psychiatry, 8:250. · DOI · Paper page
  60. Langhein M, Seitz-Holland J, Lyall AE, Pasternak O, Chunga N, Cetin-Karayumak S, et al. (2022). Association between peripheral inflammation and free-water imaging in Major Depressive Disorder before and after ketamine treatment - A pilot study. J Affect Disord, 314:78-85. · DOI
  61. Protti GG, Gagliardi RJ, Forte WC, Sprovieri SR (2013). Interleukin-10 may protect against progressing injury during the acute phase of ischemic stroke. Arq Neuropsiquiatr, 71:846-851. · DOI
  62. Laumet G, Edralin JD, Chiang AC, Dantzer R, Heijnen CJ, Kavelaars A (2018). Resolution of inflammation-induced depression requires T lymphocytes and endogenous brain interleukin-10 signaling. Neuropsychopharmacology, 43:2597-2605. · DOI
  63. Turner CA, Thompson RC, Bunney WE, Schatzberg AF, Barchas JD, Myers RM, et al. (2014). Altered choroid plexus gene expression in major depressive disorder. Front Hum Neurosci, 8:238. · DOI · Paper page
  64. Musil R, Schwarz MJ, Riedel M, Dehning S, Cerovecki A, Spellmann I, et al. (2011). Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment. J Affect Disord, 134:217-225. · DOI
  65. Kim JM, Kang HJ, Kim JW, Bae KY, Kim SW, Kim JT, et al. (2017). Associations of Tumor Necrosis Factor-alpha and Interleukin-1beta Levels and Polymorphisms with Post-Stroke Depression. Am J Geriatr Psychiatry, 25:1300-1308. · DOI
  66. Bensimon K, Herrmann N, Swardfager W, Yi H, Black SE, Gao FQ, et al. (2014). Kynurenine and depressive symptoms in a poststroke population. Neuropsychiatr Dis Treat, 10:1827-1835. · DOI
  67. Levada OA, Troyan AS (2018). Poststroke Depression Biomarkers: A Narrative Review. Front Neurol, 9:577. · DOI · Paper page
  68. Waller R, Baxter L, Fillingham DJ, Coelho S, Pozo JM, Mozumder M, et al. (2019). Iba-1-/CD68+ microglia are a prominent feature of age-associated deep subcortical white matter lesions. PLoS One, 14:e0210888. · DOI · Paper page
  69. Boche D, Perry VH, Nicoll JA (2013). Review: activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol, 39:3-18. · DOI · Paper page
  70. Wang J, Xing H, Wan L, Jiang X, Wang C, Wu Y (2018). Treatment targets for M2 microglia polarization in ischemic stroke. Biomed Pharmacother, 105:518-525. · DOI · Paper page
  71. He C, Liu R, Fan Z, Li Y, Yang M, Wugang H, et al. (2021). Microglia in the Pathophysiology of Hemorrhagic Stroke and the Relationship Between Microglia and Pain After Stroke: A Narrative Review. Pain Ther, 10:927-939. · DOI
  72. Li Q, Dai Z, Cao Y, Wang L (2019). Caspase-1 inhibition mediates neuroprotection in experimental stroke by polarizing M2 microglia/macrophage and suppressing NF-kappaB activation. Biochem Biophys Res Commun, 513:479-485. · DOI
  73. Yang L, Tucker D, Dong Y, Wu C, Lu Y, Li Y, et al. (2018). Photobiomodulation therapy promotes neurogenesis by improving post-stroke local microenvironment and stimulating neuroprogenitor cells. Exp Neurol, 299:86-96. · DOI · Paper page
  74. Nakagawa Y, Chiba K (2014). Role of microglial m1/m2 polarization in relapse and remission of psychiatric disorders and diseases. Pharmaceuticals (Basel), 7:1028-1048. · DOI · Paper page
  75. Roesch S, Rapp C, Dettling S, Herold-Mende C (2018). When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma. Int J Mol Sci, 19. · DOI · Paper page
  76. Chu F, Shi M, Zheng C, Shen D, Zhu J, Zheng X, et al. (2018). The roles of macrophages and microglia in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol, 318:1-7. · DOI · Paper page
  77. Dos Santos IRC, Dias MNC, Gomes-Leal W (2021). Microglial activation and adult neurogenesis after brain stroke. Neural Regen Res, 16:456-459. · DOI
  78. Chen AQ, Fang Z, Chen XL, Yang S, Zhou YF, Mao L, et al. (2019). Microglia-derived TNF-alpha mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke. Cell Death Dis, 10:487. · DOI · Paper page
  79. Sharma M, Arbabzada N, Flood PM (2019). Mechanism underlying beta2-AR agonist-mediated phenotypic conversion of LPS-activated microglial cells. J Neuroimmunol, 332:37-48. · DOI
  80. Zhang L, Previn R, Lu L, Liao RF, Jin Y, Wang RK (2018). Crocin, a natural product attenuates lipopolysaccharide-induced anxiety and depressive-like behaviors through suppressing NF-kB and NLRP3 signaling pathway. Brain Res Bull, 142:352-359. · DOI · Paper page
  81. Chen T, Li Z, Li S, Zou Y, Gao X, Shu S, et al. (2022). Cycloastragenol suppresses M1 and promotes M2 polarization in LPS-stimulated BV-2 cells and ischemic stroke mice. Int Immunopharmacol, 113:109290. · DOI
  82. Hsu CH, Pan YJ, Zheng YT, Lo RY, Yang FY (2023). Ultrasound reduces inflammation by modulating M1/M2 polarization of microglia through STAT1/STAT6/PPARgamma signaling pathways. CNS Neurosci Ther. · DOI
  83. Garcia JM, Stillings SA, Leclerc JL, Phillips H, Edwards NJ, Robicsek SA, et al. (2017). Role of Interleukin-10 in Acute Brain Injuries. Front Neurol, 8:244. · DOI · Paper page
  84. Xia CY, Zhang S, Gao Y, Wang ZZ, Chen NH (2015). Selective modulation of microglia polarization to M2 phenotype for stroke treatment. Int Immunopharmacol, 25:377-382. · DOI · Paper page
  85. Zhang Y, Yu P, Liu H, Yao H, Yao S, Yuan SY, et al. (2019). Hyperforin improves post-stroke social isolation-induced exaggeration of PSD and PSA via TGF-beta. Int J Mol Med, 43:413-425. · DOI
  86. Wei L, Guo J, Yu X, Chen H, Du Y, Ji Z, et al. (2021). Role and characteristics of hippocampal region microglial activation in poststroke depression. J Affect Disord, 291:270-278. · DOI
  87. Scarisbrick IA, Radulovic M, Burda JE, Larson N, Blaber SI, Giannini C, et al. (2012). Kallikrein 6 is a novel molecular trigger of reactive astrogliosis. Biol Chem, 393:355-367. · DOI
  88. Herx LM, Yong VW (2001). Interleukin-1 beta is required for the early evolution of reactive astrogliosis following CNS lesion. J Neuropathol Exp Neurol, 60:961-971. · DOI · Paper page
  89. Ponath G, Ramanan S, Mubarak M, Housley W, Lee S, Sahinkaya FR, et al. (2017). Myelin phagocytosis by astrocytes after myelin damage promotes lesion pathology. Brain, 140:399-413. · DOI · Paper page
  90. Morizawa YM, Hirayama Y, Ohno N, Shibata S, Shigetomi E, Sui Y, et al. (2017). Reactive astrocytes function as phagocytes after brain ischemia via ABCA1-mediated pathway. Nat Commun, 8:28. · DOI · Paper page
  91. Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. (2016). Schizophrenia risk from complex variation of complement component 4. Nature, 530:177-183. · DOI · Paper page
  92. Lazarov O, Mattson MP, Peterson DA, Pimplikar SW, van Praag H (2010). When neurogenesis encounters aging and disease. Trends Neurosci, 33:569-579. · DOI · Paper page
  93. O'Leary LA, Belliveau C, Davoli MA, Ma JC, Tanti A, Turecki G, et al. (2021). Widespread Decrease of Cerebral Vimentin-Immunoreactive Astrocytes in Depressed Suicides. Front Psychiatry, 12:640963. · DOI
  94. Rajkowska G, Legutko B, Moulana M, Syed M, Romero DG, Stockmeier CA, et al. (2018). Astrocyte pathology in the ventral prefrontal white matter in depression. J Psychiatr Res, 102:150-158. · DOI · Paper page
  95. Tural U, Irvin MK, Iosifescu DV (2022). Correlation between S100B and severity of depression in MDD: A meta-analysis. World J Biol Psychiatry, 23:456-463. · DOI
  96. Hidese S, Hattori K, Sasayama D, Tsumagari T, Miyakawa T, Matsumura R, et al. (2020). Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study. Transl Psychiatry, 10:161. · DOI
  97. Zhang L, Verwer RWH, Zhao J, Huitinga I, Lucassen PJ, Swaab DF (2021). Changes in glial gene expression in the prefrontal cortex in relation to major depressive disorder, suicide and psychotic features. J Affect Disord, 295:893-903. · DOI · Paper page
  98. Zhao YF, Verkhratsky A, Tang Y, Illes P (2022). Astrocytes and major depression: The purinergic avenue. Neuropharmacology, 220:109252. · DOI
  99. Peng L, Verkhratsky A, Gu L, Li B (2015). Targeting astrocytes in major depression. Expert Rev Neurother, 15:1299-1306. · DOI · Paper page
  100. Yao S, Xu MD, Wang Y, Zhao ST, Wang J, Chen GF, et al. (2023). Astrocytic lactate dehydrogenase A regulates neuronal excitability and depressive-like behaviors through lactate homeostasis in mice. Nat Commun, 14:729. · DOI
  101. Liu J, Mo JW, Wang X, An Z, Zhang S, Zhang CY, et al. (2022). Astrocyte dysfunction drives abnormal resting-state functional connectivity in depression. Sci Adv, 8:eabo2098. · DOI
  102. Gao HQ, Zhu HY, Zhang YQ, Wang LX (2008). Reduction of cerebrospinal fluid and plasma serotonin in patients with post-stroke depression: A preliminary report. Clin Invest Med, 31:E351-356. · DOI
  103. Zhao Q, Guo Y, Yang D, Yang T, Meng X (2016). Serotonin Transporter Gene 5-HTTLPR Polymorphism as a Protective Factor Against the Progression of Post-Stroke Depression. Mol Neurobiol, 53:1699-1705. · DOI
  104. Legg LA, Rudberg AS, Hua X, Wu S, Hackett ML, Tilney R, et al. (2021). Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev, 11:CD009286. · DOI
  105. Villa RF, Ferrari F, Moretti A (2018). Post-stroke depression: Mechanisms and pharmacological treatment. Pharmacol Ther, 184:131-144. · DOI · Paper page
  106. Zhang J, Ning L, Wang J (2020). Dietary quercetin attenuates depressive-like behaviors by inhibiting astrocyte reactivation in response to stress. Biochem Biophys Res Commun, 533:1338-1346. · DOI
  107. Shiroyama T, Fukuyama K, Okada M (2021). Distinct Effects of Escitalopram and Vortioxetine on Astroglial L-Glutamate Release Associated with Connexin43. Int J Mol Sci, 22. · DOI
  108. Chen B, Zhang M, Ji M, Gong W, Chen B, Zorec R, et al. (2021). The Association Between Antidepressant Effect of SSRIs and Astrocytes: Conceptual Overview and Meta-analysis of the Literature. Neurochem Res, 46:2731-2745. · DOI
  109. Fang Y, Ding X, Zhang Y, Cai L, Ge Y, Ma K, et al. (2022). Fluoxetine inhibited the activation of A1 reactive astrocyte in a mouse model of major depressive disorder through astrocytic 5-HT(2B)R/beta-arrestin2 pathway. J Neuroinflammation, 19:23. · DOI · Paper page
  110. Fang Y, Guo H, Wang Q, Liu C, Ge S, Yan B (2022). The role and mechanism of NLRP3 inflammasome-mediated astrocyte activation in dehydrocorydaline against CUMS-induced depression. Front Pharmacol, 13:1008249. · DOI
  111. Bauer ME, Teixeira AL (2019). Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci, 1437:57-67. · DOI · Paper page
  112. Cheng SY, Zhao YD, Li J, Chen XY, Wang RD, Zeng JW (2014). Plasma levels of glutamate during stroke is associated with development of post-stroke depression. Psychoneuroendocrinology, 47:126-135. · DOI
  113. Zhao A, Ma B, Xu L, Yao M, Zhang Y, Xue B, et al. (2021). Jiedu Tongluo Granules Ameliorates Post-stroke Depression Rat Model via Regulating NMDAR/BDNF Signaling Pathway. Front Pharmacol, 12:662003. · DOI
  114. Frank D, Kuts R, Tsenter P, Gruenbaum BF, Grinshpun Y, Zvenigorodsky V, et al. (2019). The effect of pyruvate on the development and progression of post-stroke depression: A new therapeutic approach. Neuropharmacology, 155:173-184. · DOI
  115. Gruenbaum BF, Kutz R, Zlotnik A, Boyko M (2020). Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-stroke depression. Ther Adv Psychopharmacol, 10:2045125320903951. · DOI
  116. Rappeneau V, Blaker A, Petro JR, Yamamoto BK, Shimamoto A (2016). Disruption of the Glutamate-Glutamine Cycle Involving Astrocytes in an Animal Model of Depression for Males and Females. Front Behav Neurosci, 10:231. · DOI
  117. Yu D, Cheng Z, Ali AI, Wang J, Le K, Chibaatar E, et al. (2019). Down-expressed GLT-1 in PSD astrocytes inhibits synaptic formation of NSC-derived neurons in vitro. Cell Cycle, 18:105-114. · DOI
  118. Martinez-Lozada Z, Guillem AM, Robinson MB (2016). Transcriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors. Adv Pharmacol, 76:103-145. · DOI
  119. Jiang MQ, Yu SP, Wei ZZ, Zhong W, Cao W, Gu X, et al. (2021). Conversion of Reactive Astrocytes to Induced Neurons Enhances Neuronal Repair and Functional Recovery After Ischemic Stroke. Front Aging Neurosci, 13:612856. · DOI
  120. Li J, Zhao YD, Zeng JW, Chen XY, Wang RD, Cheng SY (2014). Serum Brain-derived neurotrophic factor levels in post-stroke depression. J Affect Disord, 168:373-379. · DOI
  121. Xu HB, Xu YH, He Y, Xue F, Wei J, Zhang H, et al. (2018). Decreased Serum Brain-Derived Neurotrophic Factor May Indicate the Development of Poststroke Depression in Patients with Acute Ischemic Stroke: A Meta-Analysis. J Stroke Cerebrovasc Dis, 27:709-715. · DOI
  122. Noonan K, Carey LM, Crewther SG (2013). Meta-analyses indicate associations between neuroendocrine activation, deactivation in neurotrophic and neuroimaging markers in depression after stroke. J Stroke Cerebrovasc Dis, 22:e124-135. · DOI
  123. Zha Z, Liu YJ, Liu SS, Zhang N, Li JL, Qi F, et al. (2022). Bu Shen Yi Sui Capsule Promotes Myelin Repair by Modulating the Transformation of A1/A2 Reactive Astrocytes In Vivo and In Vitro. Oxid Med Cell Longev, 2022:3800004. · DOI
  124. Zhang C, Wang X, Zhu Q, Mei Y, Zhang Z, Xu H (2022). Decreased Serum Brain-Derived Neurotrophic Factor in Poststroke Depression: A Systematic Review and Meta-Analysis. Front Psychiatry, 13:876557. · DOI
  125. Shan D, Zheng Y, Froud K (2021). Brain-Derived Neurotrophic Factor as a Clinical Biomarker in Predicting the Development of Post-Stroke Depression: A Review of Evidence. Cureus, 13:e15662. · DOI
  126. Liang J, Yue Y, Jiang H, Geng D, Wang J, Lu J, et al. (2018). Genetic variations in the p11/tPA/BDNF pathway are associated with post stroke depression. J Affect Disord, 226:313-325. · DOI
  127. Lee BH, Kim YK (2010). The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment. Psychiatry Investig, 7:231-235. · DOI · Paper page
  128. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci, 22:3251-3261. · DOI · Paper page
  129. Chen HH, Zhang N, Li WY, Fang MR, Zhang H, Fang YS, et al. (2015). Overexpression of brain-derived neurotrophic factor in the hippocampus protects against post-stroke depression. Neural Regen Res, 10:1427-1432. · DOI
  130. Shah ZA, Sharma P, Vohora SB (2003). Ginkgo biloba normalises stress-elevated alterations in brain catecholamines, serotonin and plasma corticosterone levels. Eur Neuropsychopharmacol, 13:321-325. · DOI
  131. Kumar U, Medel-Matus JS, Redwine HM, Shin D, Hensler JG, Sankar R, et al. (2016). Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy. Epilepsia, 57:506-515. · DOI
  132. Lavergne F, Jay TM (2010). A new strategy for antidepressant prescription. Front Neurosci, 4:192. · DOI
  133. Skirzewski M, Karavanova I, Shamir A, Erben L, Garcia-Olivares J, Shin JH, et al. (2018). ErbB4 signaling in dopaminergic axonal projections increases extracellular dopamine levels and regulates spatial/working memory behaviors. Mol Psychiatry, 23:2227-2237. · DOI · Paper page
  134. Liu Y, Ishida Y, Shinoda K, Nakamura S (2003). Interaction between serotonergic and noradrenergic axons during axonal regeneration. Exp Neurol, 184:169-178. · DOI
  135. Zahrai A, Vahid-Ansari F, Daigle M, Albert PR (2020). Fluoxetine-induced recovery of serotonin and norepinephrine projections in a mouse model of post-stroke depression. Transl Psychiatry, 10:334. · DOI

Metadata

Authors
Lu, W., & Wen, J.
Venue
Aging and disease
Published
2025
Volume
16
Issue
1
Pages
394
ISSN
2152-5250
Cited by
54
References
33
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neuroinflammation and Post-Stroke Depression: Focus on the Microglia and Astrocytes. https://app.cochat.ai/papers/10.14336/ad.2024.0214-1
The paper
Lu, W., & Wen, J. (2025). Neuroinflammation and Post-Stroke Depression: Focus on the Microglia and Astrocytes. Aging and disease. https://doi.org/10.14336/ad.2024.0214-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.